Capone Mark Christopher 4

What Happened

• Mark Christopher Capone, a director of Mesa Laboratories Inc. (MLAB), acquired 1,301 shares via an open-market purchase on 2026-03-10.
• The purchase price was $76.35 per share, for a total transaction value of approximately $99,331. This was a buy (purchase) transaction, which is often seen as a direct insider acquisition rather than a sale.

Key Details

• Transaction date and price: 2026-03-10 at $76.35 per share.
• Shares acquired: 1,301 shares; total value ≈ $99,331.
• Transaction code: P (Purchase) — open market or private purchase.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes/plan: no 10b5-1 plan, tax withholding, or other footnotes noted in the provided data.
• Timeliness: Form 4 filed on 2026-03-10 (same day as the reported transaction).

Context

• Director purchases can signal confidence but do not prove future performance; this is a direct purchase rather than an option exercise or gift.
• The purchase size (~$99k) is modest relative to many insider transactions; the filing does not indicate 10% owner status or additional context.
• Retail investors often watch purchases like this as one input among many when evaluating insider sentiment.